BRCA1 and neoplasm: No specific association between BRCA1/2 pathogenic variants and serous endometrial cancer was detected; there was neither an increased risk of serous endometrial cancer in BRCA1/2 pathogenic variant carriers nor were pathogenic variants detected in the BRCA1/2 genes within the tumour tissue from 15 unselected serous endometrial cancers.